
-
2008
Company Description
Motus Therapeutics is a biotechnology company developing peptide therapeutics for the treatment of metabolic diseases.
Motus Therapeutics is a biotechnology company developing peptide therapeutics that address unmet needs in metabolic diseases. Rhythm investors include MPM Capital and New Enterprise Associates. The company is based in Boston, Massachusetts.
-
Manufacturer:
Science and Engineering -
Formed:
2008 -
Founders:
Bart Henderson -
Company Website:
-
Company E-mail:
-
Company Address:
855 Boylston Street, 11th FloorBoston, MAUnited States -
CEO:
- Bart Henderson
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits